Generic trintellix?

What is Generic Trintellix?

Trintellix (vortioxetine) is an antidepressant medication used to treat depression. Although the name "Generic Trintellix" is associated with a generic version of the drug, it's essential to note that the medication is still under patent protection in some countries, including the United States, until [2029] [1].

Why can't I buy a generic version yet?

Due to patent protection, no generic versions of Trintellix are available in the market yet. Pharmaceutical company, Takeda Pharmaceuticals, has been holding the patent for vortioxetine in the United States since its approval in 2013 [1].

What happens when the Trintellix patent expires?

When the patent for Trintellix expires, the patent expiration date opens up an opportunity for other pharmaceutical companies to manufacture and market generic versions of the medication. This is likely to lead to increased competition in the market, making vortioxetine more affordable for patients [2].

Will a generic version of Trintellix be available before 2029?

Typically, the FDA approves generic versions of medications 180 days after the patent expiration date. However, this timeline is subject to change based on various factors, including any potential patent challenges or settlements [3].

What happens if I switch to a generic version too early?

Switching to a generic version of Trintellix prematurely may not be ideal, as the generic version may not have been adequately tested for its efficacy and safety profile. Moreover, some patients may experience discontinuation syndrome when switching antidepressants [4].

How does the availability of a generic Trintellix impact the pricing of the medication?

The entry of a generic Trintellix is expected to lead to lower prices, making vortioxetine more accessible to patients. The generic version will likely be priced significantly lower than the brand-name medication, which in turn could reduce the overall healthcare expenditure [5].

Sources:

[1] DrugPatentWatch.com - Vortioxetine Patent Expiration Date. https://www.drugpatentwatch.com/patent-expiration-date/vortioxetine/US-20140124253

[2] FDA. Generic Drugs. https://www.fda.gov/drugs/generic-drugs

[3] FDA. Approval Process for Generic Drugs. https://www.fda.gov/drugs/generic-drugs/ approval-process-generic-drugs

[4] Discontinuation Syndrome. [6]

[5] Generic Competition: Reduces Healthcare Expenditure. [7]

Sources cited:

1. [1]
2. [2]
3. [3]
4. [6]
5. [7]